Private Equity, VC & Investor · vs · Private Equity, VC & Investor

SFC Capital vs SVQuad

Structured technology and market comparison · 2026

Direct Feature Comparison

SFC Capital · vs · SVQuad
Primary Market / Role
SFC CapitalPrivate Equity, VC & Investor
SVQuadPrivate Equity, VC & Investor
Platform Focus
SFC Capital

UK seed investor and SEIS/EIS angel fund manager.

SVQuad

Seed investor syndicate for US-incorporated technology startups.

Company Size
SFC Capital10–49 employees
SVQuad<10 employees
Headquarters
SFC CapitalGB
SVQuadUS
Year Founded
SFC Capital2012
SVQuadUnknown

Comparison Analysis

What is the main difference between SFC Capital and SVQuad?

When comparing SFC Capital and SVQuad, both platforms operate within the Private Equity, VC & Investor ecosystem. SFC Capital is positioned as UK seed investor and SEIS/EIS angel fund manager, whereas SVQuad focuses on Seed investor syndicate for US-incorporated technology startups. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.

What are the top alternatives to SFC Capital and SVQuad?

When evaluating SFC Capital and SVQuad, enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.

Market Signals

Recent Market Signals & Activity: SFC Capital vs SVQuad

Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.

SFC Capital

Recent Signals

  • ·Tech.eu (European Tech & Deals)Healthcare AI

    Anemo Labs Raises £700K for AI E-Nose

    London-based deeptech startup Anemo Labs has raised £700,000 in pre-seed funding to develop an electronic nose (e-nose) that combines sensor hardware with AI to detect volatile organic compounds (VOCs). The round was led by Zinc and SFC Capital with support from Innovate UK. Founded in 2025 by Koye Sodipo, the company initially targets healthcare applications, analyzing VOCs from urine for non-invasive disease screening. Anemo's in-house sampling platform can collect and label up to 5,000 smells daily, and early tests using the Sniffin' Sticks protocol achieved 84.15% accuracy across 12 scent categories. The funding will advance sensor chemistry, expand data collection, and support clinical validation.

    • Anemo Labs raised £700,000 in pre-seed funding.
    • The funding round was led by Zinc and SFC Capital, with support from Innovate UK.
    • Anemo Labs is developing an electronic nose combining sensor hardware and AI to detect VOCs.

SVQuad

Recent Signals

No recent market signals documented for SVQuad in the current tracking window.

Compare their exact ecosystem overlaps.

Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners SFC Capital and SVQuad share across the market ecosystem.